HSCS
HeartSciences Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.73
+11.01%Year over year
Reported trailing growth
- Revenue
- -0.7%
- EBITDA
- +99.6%
- EBIT
- -0.7%
- EPS
- +58.1%
- Free cash flow
- -0.4%
- Operating cash flow
- -0.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +17.0%
- EPS
- +36.0%
Three-year CAGR
- Revenue
- -5.7%
- EBITDA
- -2.3%
- EBIT
- -0.7%
- Net income
- -4.3%
- EPS
- +62.7%
- Free cash flow
- -0.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jan 1, 2026